Guest post: A look behind the scenes of bulk retractions from Sage

Adya Misra

When I began my graduate work almost 15 years ago, retractions of papers in academic journals were rare, reserved mainly for clear misconduct or serious errors. Today, rarity has given way to routine, with retractions coming more often and increasingly in bulk. 

Sage is not immune to large-scale retractions, nor are we passive observers of their growth. As Retraction Watch wrote, we were “one of the first publishers to recognize large-scale peer review manipulation and begin retracting papers in bulk nine years ago.” Recently, we issued some major retractions; just in the last few months, we put out 37 from Proceedings of the Institution of Mechanical Engineers and 21 from Concurrent Engineering. And there are more to come. 

While we don’t celebrate this type of action, the news is not all bad. The high numbers of retractions at times reflect a problem of industrialized cheating, but also, as in our case, a belief that rigorous scholarship – robustly reviewed by researchers who are experts in their fields – can and should improve the world. Sage was founded on this principle, and it guides everything we do. 

We take our role of vigorously correcting the academic record very seriously because we believe in the scholarly process. We also know that every part of the process is managed by humans with biases (conscious or unconscious), agendas, heavy workloads, and – at times – dubious incentives.  

As research integrity manager at Sage, I work to safeguard the credibility of the research published in more than 60,000 articles every year across more than 1,100 journals. In my role, I see a lot of unethical practices: peer review rings, where researchers unfairly influence the review process; paper mills that produce mass-fabricated research papers, and the brazen trend of selling authorship or entire papers on private or public forums. When it comes to preventing and correcting this type of action,  much goes on behind the scenes.

Continue reading Guest post: A look behind the scenes of bulk retractions from Sage

Research integrity during the COVID-19 pandemic: A book excerpt

Ferric Fang

We are pleased to present an excerpt from Thinking About Science: Good Science, Bad Science, and How to Make It Better by Ferric C. Fang and Arturo Casadevall, published by ASM Press/Wiley, October 2023.

Amidst the COVID-19 calamity, one can argue that science is one of the few aspects of the human response that has worked relatively well. However, despite the many advances in preventing and treating COVID-19, there have also been missteps as the world has scrambled to respond to a deadly new pathogen. It has been humbling for the U.S. to lead large high-income countries in per capita deaths from COVID-19 even with its wealth and scientific expertise. We are all too aware of the needless illnesses and deaths that have resulted from misguided political leadership, inadequate preparation, delayed responses, fragile supply chains, health disparities, and vaccine hesitancy. But we will not dwell on these issues here. Rather, we would like to review the COVID-19 pandemic through the prism of the 3R’s of research integrity: rigor, reproducibility, and responsibility. These form the fundamental pillars of the foundation of science. It is appropriate that we devote more attention to the foibles than to the successes so that we can learn from the mistakes and missed opportunities. What could have been done better? What needs to improve?

Continue reading Research integrity during the COVID-19 pandemic: A book excerpt

Weekend reads: UK shadow chancellor accused of plagiarism; eLife editor fired; Elsevier editor resigns because publisher ignored likely paper mill activity

Would you consider a donation to support Weekend Reads, and our daily work?

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up to well over 350. There are more than 43,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains well over 200 titles. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers? Or The Retraction Watch Mass Resignations List?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Continue reading Weekend reads: UK shadow chancellor accused of plagiarism; eLife editor fired; Elsevier editor resigns because publisher ignored likely paper mill activity

Lancet retracts two more papers by convicted surgeon Paolo Macchiarini

Paolo Macchiarini

The Lancet today retracted two papers by former Karolinska Institutet surgeon Paolo Macchiarini, whose professional and personal escapades have made headlines for more than a decade and who has been sentenced to 30 months in prison for causing bodily harm to his patients.

The move comes a month after Sweden’s National Board for Assessment of Misconduct (NPOF in Swedish) said it had found Macchiarini guilty of misconduct involving the two articles, eight months after the journal issued expressions of concern for the two papers, and five years after Macchiarini had already been found to have committed misconduct in related work.

As we reported in February:

Continue reading Lancet retracts two more papers by convicted surgeon Paolo Macchiarini

History repeats itself: Diabetes researcher gets four expressions of concern in journal he once sued

Mario Saad

A diabetes researcher who lost a defamation suit against a journal that marked four of his papers with expressions of concern now has four more papers flagged – by the same journal. 

Diabetes, a journal of the American Diabetes Association (ADA), placed expressions of concern on four papers led or co-authored by Mario Saad, of the University of Campinas (Unicamp) in Brazil on October 23. 

Saad sued the ADA in 2015 after Diabetes marked four other papers with similar notices. A judge dismissed the suit, and the journal later retracted the papers (for which we recognized them with a DiRT — Doing the Right Thing — award). Saad is now up to 19 retractions, by our count

Continue reading History repeats itself: Diabetes researcher gets four expressions of concern in journal he once sued

Publisher looking into COVID vaccine paper with ‘serious flaws’

A controversial paper on the safety and immunogenicity of an Iran-made COVID-19 vaccine is being investigated by the U.S.-based publisher Wiley, Retraction Watch has learned.

Iran reportedly has already administered 3 million doses of the vaccine, dubbed Noora, which the country licensed for emergency use last year.

The paper describes the vaccine’s first test in humans, marking the only time results from the clinical development of the homegrown shot have been reported in international journals.

Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial” was published in 2022 in the Journal of Medical Virology, an achievement highlighted in Iranian news media. One report said the study showed a dose of 80 micrograms of the vaccine was “safe” and provided “adequate immunity in adults.” 

Continue reading Publisher looking into COVID vaccine paper with ‘serious flaws’

Cancer researcher with nine retractions says he’ll take publisher to court

Mostafa Jarahian

A cancer researcher who lost nine papers in one day as a publisher purged articles offered in “authorship-for-sale” schemes told Retraction Watch he and his co-authors “will soon defend ourselves legally.” 

Last month, the publisher Frontiers announced it had retracted 38 papers after its research integrity team found links to the practice of buying and selling authorship positions. Brokers list advertisements for authorships of scientific papers on dedicated websites as well as social media.  

Nine of the 38 articles Frontiers retracted listed Mostafa Jarahian, formerly of the German Cancer Research Center (DKFZ) in Heidelberg, as a co-author. 

When we initially reported on the large batch of retractions, one of Jarahian’s co-authors shared an article from Frontiers  indicating the publisher had decided to retract the paper after “concerns were brought to our attention from the German Cancer Research Center regarding the authorship of the article.” 

Continue reading Cancer researcher with nine retractions says he’ll take publisher to court

PLOS and scientist appear close to settling lawsuit over expression of concern

Soudamani Singh

The publisher PLOS appears close to an agreement with a scientist who sued to stop the addition of an expression of concern to one of her articles, according to a recent filing in the case. 

Soudamani Singh, an assistant professor in the Department of Clinical and Translational Sciences at Marshall University’s Joan C. Edwards School of Medicine in Huntington, W. Va., filed suit against PLOS in April, as we previously reported

According to Singh’s complaint, the publisher planned to place an expression of concern on one of her papers after she and her co-authors had requested a correction. 

Singh’s suit sought a temporary restraining order and permanent injunction preventing PLOS from publishing the expression of concern, as well as damages and legal fees. 

Continue reading PLOS and scientist appear close to settling lawsuit over expression of concern

Weekend reads: A Nobelist earns an expression of concern; India’s fake universities; shaking things up in psychology

Would you consider a donation to support Weekend Reads, and our daily work?

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up to well over 350. There are more than 43,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains well over 200 titles. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers? Or The Retraction Watch Mass Resignations List?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Continue reading Weekend reads: A Nobelist earns an expression of concern; India’s fake universities; shaking things up in psychology

Professor who blamed plagiarism on ghostwriter to earn first retraction

A professor in France who plagiarized extensively in a review article and then blamed the offense on an undisclosed medical writer will lose the publication, Retraction Watch has learned.

“We have decided to retract this paper,” Yi-Xiang Wang, editor-in-chief of Quantitative Imaging in Medicine and Surgery, told us by email.

The move comes one day after a Retraction Watch exclusive describing how the professor, Romaric Loffroy of CHU Dijon Bourgogne, claimed he had not written the offending paper despite being listed as its first and corresponding author. Instead, Loffroy put the blame on an alleged medical writer.

The retraction will be Loffroy’s first. He did not immediately respond to our request for comments.

Continue reading Professor who blamed plagiarism on ghostwriter to earn first retraction